574 related articles for article (PubMed ID: 28157104)
1. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.
Khan W; Giampietro V; Banaschewski T; Barker GJ; Bokde AL; Büchel C; Conrod P; Flor H; Frouin V; Garavan H; Gowland P; Heinz A; Ittermann B; Lemaître H; Nees F; Paus T; Pausova Z; Rietschel M; Smolka MN; Ströhle A; Gallinat J; Vellas B; Soininen H; Kloszewska I; Tsolaki M; Mecocci P; Spenger C; Villemagne VL; Masters CL; Muehlboeck JS; Bäckman L; Fratiglioni L; Kalpouzos G; Wahlund LO; Schumann G; Lovestone S; Williams SC; Westman E; Simmons A; ; ;
J Alzheimers Dis; 2017; 56(3):1159-1174. PubMed ID: 28157104
[TBL] [Abstract][Full Text] [Related]
2. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.
Lim YY; Williamson R; Laws SM; Villemagne VL; Bourgeat P; Fowler C; Rainey-Smith S; Salvado O; Martins RN; Rowe CC; Masters CL; Maruff P;
J Alzheimers Dis; 2017; 58(4):1293-1302. PubMed ID: 28550258
[TBL] [Abstract][Full Text] [Related]
3. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
[TBL] [Abstract][Full Text] [Related]
5. Bilateral Hippocampal Volume Mediated the Relationship Between Plasma BACE1 Concentration and Memory Function in the Early Stage of Alzheimer's Disease: A Cross-Sectional Study.
Yin W; Wan K; Zhu W; Zhou X; Tang Y; Zheng W; Cao J; Song Y; Zhao H; Zhu X; Sun Z
J Alzheimers Dis; 2023; 92(3):1001-1013. PubMed ID: 36847009
[TBL] [Abstract][Full Text] [Related]
6. 18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
Zhao Z; Wang J; Wang Y; Liu X; He K; Guo Q; Xie F; Huang Q; Li Z
J Alzheimers Dis; 2023; 93(2):585-594. PubMed ID: 37066915
[TBL] [Abstract][Full Text] [Related]
7. Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment.
Chiang GC; Insel PS; Tosun D; Schuff N; Truran-Sacrey D; Raptentsetsang ST; Thompson PM; Reiman EM; Jack CR; Fox NC; Jagust WJ; Harvey DJ; Beckett LA; Gamst A; Aisen PS; Petersen RC; Weiner MW;
Alzheimers Dement; 2011 Sep; 7(5):514-20. PubMed ID: 21889115
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.
Chung JK; Plitman E; Nakajima S; Caravaggio F; Iwata Y; Gerretsen P; Kim J; Takeuchi H; Shinagawa S; Patel R; Chakravarty MM; Graff-Guerrero A;
J Alzheimers Dis; 2017; 58(3):747-762. PubMed ID: 28505977
[TBL] [Abstract][Full Text] [Related]
9. Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.
Bangen KJ; Clark AL; Werhane M; Edmonds EC; Nation DA; Evangelista N; Libon DJ; Bondi MW; Delano-Wood L;
J Alzheimers Dis; 2016 Mar; 52(3):849-61. PubMed ID: 27031472
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Gender and APOE ɛ4 Status on Brain Amyloid-β Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study.
Wang J; Wang M; Ren S; Huang L; He K; Li J; Hua F; Guan Y; Guo Q; Huang Q; Xie F
J Alzheimers Dis; 2023; 94(2):763-775. PubMed ID: 37334590
[TBL] [Abstract][Full Text] [Related]
11. Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.
Tomaszewski N; He X; Solomon V; Lee M; Mack WJ; Quinn JF; Braskie MN; Yassine HN
J Alzheimers Dis; 2020; 74(3):975-990. PubMed ID: 32116250
[TBL] [Abstract][Full Text] [Related]
12. Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
Bejanin A; Iulita MF; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernandez S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Padilla C; Aranha MR; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Zetterberg H; Blennow K; Alcolea D; Clarimon J; Zaman SH; Blesa R; Lleó A; Fortea J
JAMA Neurol; 2021 Aug; 78(8):937-947. PubMed ID: 34228042
[TBL] [Abstract][Full Text] [Related]
13. Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults.
Kang DW; Wang SM; Um YH; Kim NY; Lee CU; Lim HK
J Alzheimers Dis; 2022; 89(3):1003-1016. PubMed ID: 35964194
[TBL] [Abstract][Full Text] [Related]
14. Cognitive Improvement After Multi-Domain Lifestyle Interventions in an APOE ɛ4 Homozygous Carrier with Mild Cognitive Impairment: A Case Report and Literature Review.
Miao Y; Cui L; Li J; Chen Y; Xie X; Guo Q
J Alzheimers Dis; 2022; 89(4):1131-1142. PubMed ID: 35988223
[TBL] [Abstract][Full Text] [Related]
15. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Laws SM; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Rembach A; Martins RN; Rowe CC; Masters CL; Maruff P
Mol Psychiatry; 2015 Nov; 20(11):1322-8. PubMed ID: 25288138
[TBL] [Abstract][Full Text] [Related]
16. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
[TBL] [Abstract][Full Text] [Related]
17. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
18. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
[TBL] [Abstract][Full Text] [Related]
19. APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.
Toledo JB; Habes M; Sotiras A; Bjerke M; Fan Y; Weiner MW; Shaw LM; Davatzikos C; Trojanowski JQ;
J Alzheimers Dis; 2019; 69(3):783-793. PubMed ID: 31127775
[TBL] [Abstract][Full Text] [Related]
20. Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease.
Verdile G; Laws SM; Henley D; Ames D; Bush AI; Ellis KA; Faux NG; Gupta VB; Li QX; Masters CL; Pike KE; Rowe CC; Szoeke C; Taddei K; Villemagne VL; Martins RN;
Mol Psychiatry; 2014 Jan; 19(1):69-75. PubMed ID: 23089633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
